CRISPR Therapeutics AG

2. Okt. 2026, 20:07 UTC

CRISPR Therapeutics AG shares fell sharply, pulling back from earlier gains amid a broader market trend of slight declines since Thursday's close.

1. Okt. 2026, 20:07 UTC

CRISPR Therapeutics AG advanced during Thursday's trading session, reflecting a modest gain since Wednesday's close, despite earlier pulling back from a session high.

30. Sept. 2026, 23:01 UTC

CRISPR Therapeutics AG is trading modestly higher in after-market hours following a pullback from an earlier peak during the regular session.

29. Sept. 2026, 23:06 UTC

CRISPR Therapeutics AG's shares were roughly flat during after-market hours, trading within a narrow range and above the 20-day moving average.

28. Sept. 2026, 22:31 UTC

CRISPR Therapeutics AG advanced during after-market hours, continuing its upward movement despite a recent trend of lower trading in the broader biotechnology sector.

25. Sept. 2026, 23:00 UTC

CRISPR Therapeutics AG sees a modest increase in after-market trading following Friday's close, positioned around the midpoint of its one-month trading range.

24. Sept. 2026, 23:00 UTC

CRISPR Therapeutics AG is trading lower in after-market hours, reaching its lowest point since Thursday amid rising Treasury yields and geopolitical tensions.

23. Sept. 2026, 20:02 UTC

Shares of CRISPR Therapeutics AG are declining sharply following Anthropic's announcement of a novel enzyme system with similarities to CRISPR, raising competitive concerns.

22. Sept. 2026, 23:31 UTC

CRISPR Therapeutics AG is rising in after-market trading, gaining ground since Tuesday's close and remaining above its 20-day moving average.

21. Sept. 2026, 23:51 UTC

CRISPR Therapeutics AG is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

19. Sept. 2026, 00:02 UTC

CRISPR Therapeutics AG is advancing in after-market trading, likely in sympathy with Editas Medicine Inc, amid broader economic concerns.

18. Sept. 2026, 23:01 UTC

CRISPR Therapeutics AG is advancing in after-market trading, moving higher alongside the broader market, following a peak return earlier in the session.

17. Sept. 2026, 23:51 UTC

CRISPR Therapeutics AG declined modestly during after-market hours on Thursday, breaking a recent trend of higher daily closes.

16. Sept. 2026, 23:16 UTC

CRISPR Therapeutics AG is declining in after-market hours, trading near the lower end of its one-month range and below its 20-day moving average.

15. Sept. 2026, 23:01 UTC

CRISPR Therapeutics AG shares are higher in after-market hours, reflecting overall market momentum despite a decline in the New York Empire State Manufacturing Index.

14. Sept. 2026, 23:01 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting a strong performance despite declining major indices and rising crude oil prices.

11. Sept. 2026, 23:01 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, influenced by a narrower-than-expected U.S. budget deficit of $167 billion for August.

10. Sept. 2026, 20:07 UTC

CRISPR Therapeutics AG shares are lower amid a broader market decline following the European Central Bank's interest rate hike and rising Treasury yields.

8. Sept. 2026, 20:07 UTC

CRISPR Therapeutics AG shares are lower today, marking four consecutive sessions of declines amid market speculation on potential interest rate hikes.

4. Sept. 2026, 23:37 UTC

CRISPR Therapeutics AG shares rose in after-market trading, reflecting a modest increase since Friday's close, aligning with Beam Therapeutics' sector performance.

3. Sept. 2026, 23:56 UTC

CRISPR Therapeutics AG shares are lower in after-hours trading, continuing a decline since Thursday's close, despite broader market gains. No specific news was identified.

2. Sept. 2026, 19:46 UTC

CRISPR Therapeutics AG shares are lower today, continuing a four-day decline amid rising U.S. Treasury yields and inflationary pressures affecting the biotechnology sector.

1. Sept. 2026, 23:06 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, with no specific news identified to explain the movement. The stock has declined in three consecutive sessions.

31. Aug. 2026, 23:06 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting stable performance amid broader economic sentiment and expectations for a potential rate hike.

29. Aug. 2026, 00:02 UTC

CRISPR Therapeutics AG shares are lower in after-market hours, continuing a trend of notable weakness amid rising market expectations for an interest rate hike.

28. Aug. 2026, 22:51 UTC

CRISPR Therapeutics AG shares are lower in after-market hours, continuing a trend of weakness since Friday's close with no specific news identified.

27. Aug. 2026, 23:02 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting overall strength despite a slight pullback from earlier highs. No specific news was identified.

26. Aug. 2026, 23:02 UTC

CRISPR Therapeutics AG shares are higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

25. Aug. 2026, 23:06 UTC

CRISPR Therapeutics AG shares are lower in after-market hours, reflecting a decline after Tuesday's close, despite a significant gain over the past month.

24. Aug. 2026, 23:01 UTC

Shares of CRISPR Therapeutics AG declined in after-market trading, despite briefly recovering earlier in the session. The stock remains above its 20-day moving average.